Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
89.9M
-
Number of holders
-
89
-
Total 13F shares, excl. options
-
35.3M
-
Shares change
-
+501K
-
Total reported value, excl. options
-
$487M
-
Value change
-
+$8.86M
-
Number of buys
-
35
-
Number of sells
-
-48
-
Price
-
$13.80
Significant Holders of IDEAYA Biosciences, Inc. - Common Stock (IDYA) as of Q2 2022
106 filings reported holding IDYA - IDEAYA Biosciences, Inc. - Common Stock as of Q2 2022.
IDEAYA Biosciences, Inc. - Common Stock (IDYA) has 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.3M shares
of 89.9M outstanding shares and own 39.25% of the company stock.
Largest 10 shareholders include Logos Global Management LP (3.75M shares), Avidity Partners Management LP (2.97M shares), BVF INC/IL (2.79M shares), Canaan Partners X LLC (2.66M shares), BlackRock Inc. (2.62M shares), BOXER CAPITAL, LLC (2.2M shares), FEDERATED HERMES, INC. (2.16M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.89M shares), VANGUARD GROUP INC (1.75M shares), and Point72 Asset Management, L.P. (1.51M shares).
This table shows the top 89 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.